Axon Enterprise, Inc. (NASDAQ:AXON) Shares Acquired by Harvest Fund Management Co. Ltd

Harvest Fund Management Co. Ltd increased its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 148.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 801 shares of the biotechnology company’s stock after purchasing an additional 479 shares during the period. Harvest Fund Management Co. Ltd’s holdings in Axon Enterprise were worth $202,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. BKM Wealth Management LLC bought a new stake in Axon Enterprise in the 4th quarter valued at about $32,000. Key Financial Inc raised its holdings in shares of Axon Enterprise by 367.6% during the fourth quarter. Key Financial Inc now owns 159 shares of the biotechnology company’s stock valued at $41,000 after buying an additional 125 shares during the last quarter. Lindbrook Capital LLC grew its holdings in Axon Enterprise by 43.3% in the 4th quarter. Lindbrook Capital LLC now owns 172 shares of the biotechnology company’s stock worth $44,000 after buying an additional 52 shares in the last quarter. Rakuten Securities Inc. acquired a new stake in Axon Enterprise in the 4th quarter valued at approximately $48,000. Finally, Provence Wealth Management Group bought a new stake in Axon Enterprise during the 3rd quarter valued at $80,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on AXON. StockNews.com lowered Axon Enterprise from a “buy” rating to a “hold” rating in a report on Thursday, March 14th. Morgan Stanley raised their target price on shares of Axon Enterprise from $250.00 to $285.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 28th. The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $297.00 to $339.00 and gave the stock a “buy” rating in a research note on Wednesday, February 28th. TheStreet lowered shares of Axon Enterprise from a “b” rating to a “c+” rating in a research note on Tuesday, February 27th. Finally, William Blair reaffirmed an “outperform” rating on shares of Axon Enterprise in a research note on Wednesday. Two analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $312.64.

Axon Enterprise Stock Up 0.3 %

Shares of NASDAQ:AXON opened at $302.41 on Thursday. The firm has a 50 day simple moving average of $302.15 and a 200 day simple moving average of $260.29. Axon Enterprise, Inc. has a 52 week low of $175.37 and a 52 week high of $329.87. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.66 and a current ratio of 3.00. The company has a market cap of $22.82 billion, a PE ratio of 131.48 and a beta of 0.93.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.29. The company had revenue of $432.14 million for the quarter, compared to the consensus estimate of $418.97 million. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. As a group, research analysts expect that Axon Enterprise, Inc. will post 2.44 earnings per share for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.